Atralin

Active Ingredient(s): Tretinoin
FDA Approved: * July 26, 2007
Pharm Company: * CORIA
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Atralin Overview

Tretinoin, also known as all-trans retinoic acid (ATRA), is medication used for the treatment of acne and acute promyelocytic leukemia.[1][2][3] For acne, it is applied to the skin as a cream or ointment.[3] For leukemia, it is taken by mouth for up to three months.[1] Common side effects when used by mouth include shortness of breath, headache, numbness, depression, skin dryness, itchiness, hair loss, vomiting, m...

Read more Atralin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tretinoin

Recent Atralin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tretinoin
  • Capsule: 10mg
  • Cream: 0.02%, 0.025%, 0.03%, 0.05%, 0.1%, 0.10%
  • Gel: 0.01%, 0.025%, 0.03%, 0.04%, 0.05%, 0.1%
  • Liquid: 0.05%
  • Lotion: 0.05%
  • Solution: 0.05%, 0.5%
  • Swab: 0.05%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Atralin: (1 result)

Sorted by National Drug Code
  • 13548-070 Atralin .05 g/100g Topical Gel by Coria Laboratories

Other drugs which contain Tretinoin or a similar ingredient: (26 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA